Clinical Trial: Association between HDL Cholesterol Efflux Capacity, HDL Subclass Fractionation, and Anti-VEGF Treatment Responsiveness with SGLT2 Inhibitors in Patients with Type 2 Diabetes and Diabetic Macular Edema: An Exploratory Study Using Stored Samples from the COMET Trial (Japan)

Tokyo, Aug. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062509) titled 'Association between HDL Cholesterol Efflux Capacity, HDL Subclass Fractionation, and Anti-VEGF Treatment Responsiveness with SGLT2 Inhibitors in Patients with Type 2 Diabetes and Diabetic Macular Edema: An Exploratory Study Using Stored Samples from the COMET Trial' on Aug. 7.

Study Type: Observational

Primary Sponsor: Institute - Chiba University

Condition: Condition - Type 2 Diabetes and Diabetic Macular Edema Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - In a post-hoc analysis of the COMET trial (luseogliflozin vs. glimepiride in patients with type 2 diabetes...